News & Announcements
Assistant Dean at Temple University School of Medicine Selected One of Region's Most Influential Latinos
Raul A. DeLa Cadena, MD, Assistant Dean and Director of the Recruitment, Admissions and Retention (RAR) Program at Temple University School of Medicine, has been selected as one of the "Delaware Valley's Most Influential Latinos" for 2012. He was selected for the honor by the Most Influential Latinos Foundation, whose stated mission is to support and encourage Latino leadership and empowerment. Dr. DeLa Cadena will be recognized, along with the other honorees, at a Gala Dinner and celebration on November 29 in Philadelphia.
"This is a great honor for which I am pleased to be recognized," said Dr. DeLa Cadena. "It is also a reflection on Temple University School of Medicine's proud legacy of helping disadvantaged students overcome academic and economic obstacles that contribute to their underrepresentation among our nation's physicians."
As Director of Temple's RAR Program, Dr. DeLa Cadena works to enhance the recruitment of underrepresented minorities to the School of Medicine. The primary purpose of the RAR Program is to help Temple identify, enroll, retain and graduate physicians from such backgrounds to infuse diversity into the healthcare workforce in the profession of medicine both regionally and nationally.
"This selection of Dr. DeLa Cadena as one of the region's most influential Latinos is well deserved," said Arthur M. Feldman, MD, PhD, Executive Dean of Temple University School of Medicine. "Dr. DeLa Cadena works tirelessly to help Temple actualize its commitment to diversity in its student body, while also maintaining excellence in its academic programs."
Dr. DeLa Cadena also serves as Professor of Physiology and holds a faculty appointment at Temple's Sol Sherry Thrombosis Research Center. His research focuses on the pathophysiology of Diabetic Retinopathy and Rheumatoid Arthritis.
Date Published: Wednesday, November 21, 2012
back | view all news
Temple University Hospital Testing a Promising New Lupus Drug
A recently approved Phase III clinical trial being conducted at Temple University Hospital is investigating whether a new, investigational drug for lupus is more effective than medications currently in use.
read more »
Temple University Health System Hospitals to be Honored at Philadelphia’s City Hall for Their Healthy Food Initiatives
Temple University Hospital, Temple University Hospital-Episcopal Campus and Jeanes Hospital are three of the six Philadelphia hospitals being honored at Philadelphia’s City Hall for their efforts to reduce and prevent chronic disease by serving fresh, local, healthy food to their patients, employees and visitors.
read more »
Larry Kaiser, MD, FACS, President & CEO of Temple University Health System, Named a “Physician Leader” by Becker’s Hospital Review
Larry R. Kaiser, MD, FACS, President and CEO of Temple University Health System, Dean and Professor of Surgery at the Lewis Katz School of Medicine at Temple University, and Senior Executive Vice President for Health Affairs at Temple University, has been named one of the top “Physician Leaders of Hospitals and Health Systems” by Becker’s Hospital Review.
read more »